ORCID as entered in ROS

Select Publications
2021, 'Barriers to seeking help among music festival attendees in New South Wales, Australia', presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384
,2021, 'Symposium: An update on pharmacotherapy trials for substance use disorder - methamphetamine type and withdrawal in Australia', presented at The APSAD Scientific Drug and Alcohol Conference, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384
,2021, 'The future of pharmacotherapy clinical trials in Australia: the OLAM trial; the MOXY trial; the PSIMA trial; the TINA trial', presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384
,2024, 'Nitrous oxide presentations: the growing trend of nitrous oxide cylinder usage', in Toxicology Communications, Taylor & Francis Group, Melbourne, Victoria, Vol. 8, presented at Toxicology and Poisons Network Australasia (TAPNA) 2024 Annual Scientific Meeting, Melbourne, Victoria, https://doi.org/10.1080/24734306.2024.2372936
,2024, 'Nitrous oxide presentations: the growing trend of nitrous oxide cylinder usage', in Clinical Toxicology, Taylor and Francis Group, Munich, Germany, Vol. 62, pp. 43 - 43, presented at 44th International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT), Munich, Germany, https://doi.org/10.1080/15563650.2024.2333651
,2023, 'Oral naltrexone-bupropion combination pharmacotherapy for methamphetamine use disorder: Pilot study protocol', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749
,2023, 'Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749
,2023, 'Psilocybin-assisted psychotherapy for methamphetamine use disorder: Recruitment to a novel safety and feasibility trial', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749
,2023, 'OBJECTIVE AND SUBJECTIVE SLEEP DURING LISDEXAMFETAMINE TREATMENT OF ACUTE METHAMPHETAMINE WITHDRAWAL: NEW MEASUREMENT PARADIGM', in DRUG AND ALCOHOL DEPENDENCE, ELSEVIER IRELAND LTD, CO, Denver, Vol. 260, presented at 85th Annual Scientific Meeting of the College-on-Problems-of-Drug-Dependence (CPDD), CO, Denver, 17 July 2023 - 21 July 2023, http://dx.doi.org/10.1016/j.drugalcdep.2023.110067
,2022, '"Sometimes I have a duty of care not to call 000": Reported practices, attitudes and factors influencing consumer responses to GHB overdose', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S64 - S64, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'An exploratory analysis of actigraphy and sleep diaries in a methamphetamine withdrawal clinical trial', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S23 - S24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Patterns of ADHD medicine use: A population-based study among Australian children and adults (2013-2020)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 71 - 71, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084400136&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Trajectories of pregabalin use and their association with longitudinal changes in opioid and benzodiazepine use', in Pain, Wolters Kluwer, United States, Vol. 163, pp. E614 - E621, United States, http://dx.doi.org/10.1097/j.pain.0000000000002433
,2022, 'A study protocol for the PsiMA trial: Psilocybin assisted psychotherapy for methamphetamine use disorder', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S82 - S82
,2020, 'Just "nanging" around: case series of neurological sequelae from chronic nitrous oxide abuse', in CLINICAL TOXICOLOGY, TAYLOR & FRANCIS LTD, Vol. 58, pp. 568 - 568, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000531053300149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'A day in the life: Prescription medicine use in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 545 - 545, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785604064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, Is it worth the weight?
,